The impact of adding mitomycin-C to radiotherapy plus oral tegafur-uracil on advanced-stage rectal cancer

被引：3
|
作者：
Li, Yiu-Tai [1 ]
Chang, Wen-Hsun [2 ,3 ,4 ,5 ]
机构：
[1] Kuo Gen Hosp, Dept Obstet & Gynecol, Tainan, Taiwan
[2] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan
[5] Taipei Vet Gen Hosp, Dept Nursing, 201,Sect 2,Shi Pai Rd, Taipei 112, Taiwan
来源：
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION | 2023年 / 86卷 / 02期
关键词：
D O I：
10.1097/JCMA.0000000000000856
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [31] Randomized phase II study of tegafur-uracil/leucovorin versus tegafur-uracil/leucovorin plus oxaliplatin after curative resection of high-risk stage II/III colorectal cancer (SOAC-1101 trial)
    Kosugi, Chihiro
    Koda, Keiji
    Takiguchi, Nobuhiro
    Takaishi, Satoru
    Miyauchi, Hideaki
    Hirayama, Nobuo
    Nomura, Yukihiro
    Kondo, Eisuke
    Kawasaki, Yohei
    Ozawa, Yoshihito
    Matsubara, Hisahiro
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (08) : 1739 - 1749
  • [32] The Efficacy of Oral Tegafur-Uracil as Maintenance Therapy Following Intravenous 5-Fluorouracil Chemotherapy in Stage III Colon Cancer
    Hong, Kwang Dae
    Lee, Sun Il
    Moon, Hong Young
    HEPATO-GASTROENTEROLOGY, 2012, 59 (113) : 104 - 107
  • [33] Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial
    Nakajima, T
    Nashimoto, A
    Kitamura, M
    Kito, T
    Iwanaga, T
    Okabayashi, K
    Goto, M
    LANCET, 1999, 354 (9175): : 273 - 277
  • [34] Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
    Alliot, C
    BRITISH JOURNAL OF CANCER, 2004, 91 (06) : 1220 - 1221
  • [35] Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
    C Alliot
    British Journal of Cancer, 2004, 91 : 1220 - 1221
  • [36] Phase I dosing-escalating study of oxaliplatin in combination with oral tegafur-uracil/leucorvin in patients with advanced gastric cancer
    Chen, JS
    Huang, JS
    Yang, TS
    Lin, YC
    Wang, HM
    Liau, CT
    Rau, KM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 379S - 379S
  • [37] Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer
    Schiebe, ME
    Reese, T
    Wenz, F
    Schmidberger, H
    Engenhart-Cabillic, R
    Dunst, A
    Hess, CF
    Hoffmann, W
    ANTI-CANCER DRUGS, 2002, 13 (10) : 1005 - 1009
  • [38] Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis
    Ryosuke Nakagawa
    Yuji Inoue
    Takeshi Ohki
    Yuka Kaneko
    Fumi Maeda
    Masakazu Yamamoto
    World Journal of Surgical Oncology, 15
  • [39] Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum
    Seto, Takashi
    Yamanaka, Takeharu
    Nakano, Makiko
    Ota, Mayuko
    Maruyama, Riichiroh
    Okamoto, Tatsuro
    Wataya, Hiroshi
    Uematsu, Kazutsugu
    Seki, Nobuhiko
    Eguchi, Kenji
    Semba, Hiroshi
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : 637 - 642
  • [40] Oral Tegafur-Uracil Combination plus Leucovorin versus Other Fluoropyrimidine Agents in Colorectal Cancer: A Systematic Review and Meta-Analysis
    Kataria, Satya Pal
    Nagar, Mukesh
    Verma, Shikha
    Purohit, Vinay
    SOUTH ASIAN JOURNAL OF CANCER, 2022, 11 (01) : 84 - 94
12345